Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert L Murphy

Showing results (91-100 of 176) with videos related to

Pageof 18
Sort By:
Journal of Infection in Developing Countries|December 1, 2024
The impact of HIV antiretroviral therapy on gut microbiota: the need for well-designed longitudinal studiesOumar Dolo, Fousseini Coulibaly, Anou M Somboro, et al.
Epigenomics|June 12, 2018
Promoter methylation of PGC1A and PGC1B predicts cancer incidence in a veteran cohortJacob K Kresovich, Brian T Joyce, Tao Gao, et al.
AIDS (London, England)|September 16, 2015
A prospective, randomized clinical trial of antiretroviral therapies on carotid wall thicknessJames H Stein, Heather J Ribaudo, Howard N Hodis, et al.
Antimicrobial Agents and Chemotherapy|September 23, 2015
Artemether-Lumefantrine Exposure in HIV-Infected Nigerian Subjects on Nevirapine-Containing Antiretroviral TherapySunil Parikh, Fatai Fehintola, Liusheng Huang, et al.
JMIR Public Health and Surveillance|July 16, 2024
South Asia's COVID-19 History and Surveillance: Updated Epidemiological AssessmentLori A Post, Alan G Soetikno, Scott A Wu, et al.
JMIR Public Health and Surveillance|July 16, 2024
Updated Surveillance Metrics and History of the COVID-19 Pandemic (2020-2023) in Sub-Saharan Africa: Longitudinal Trend AnalysisAlexander L Lundberg, Alan G Soetikno, Scott A Wu, et al.
AIDS (London, England)|March 21, 2003
A phase II clinical study of the long-term safety and antiviral activity of enfuvirtide-based antiretroviral therapyJacob P Lalezari, Joseph J Eron, Margrit Carlson, et al.
Infectious Agents and Cancer|December 5, 2019
HIV status, age at cervical Cancer screening and cervical cytology outcomes in an opportunistic screening setting in Nigeria: a 10-year Cross sectional data analysisJonah Musa, Chad J Achenbach, Charlesnika T Evans, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 13, 2015
Superior Effectiveness of Zidovudine Compared With Tenofovir When Combined With Nevirapine-based Antiretroviral Therapy in a Large Nigerian CohortKimberly K Scarsi, Geoffrey Eisen, Kristin M Darin, et al.
AIDS Research and Treatment|April 14, 2012
Nevirapine-Based Antiretroviral Therapy Impacts Artesunate and Dihydroartemisinin Disposition in HIV-Infected Nigerian AdultsFatai A Fehintola, Kimberly K Scarsi, Qing Ma, et al.
Pageof 18

Showing results (91-100 of 176) with videos related to

Sort By:
Pageof 18
Journal of Infection in Developing Countries|December 1, 2024
The impact of HIV antiretroviral therapy on gut microbiota: the need for well-designed longitudinal studiesOumar Dolo, Fousseini Coulibaly, Anou M Somboro, et al.
Epigenomics|June 12, 2018
Promoter methylation of PGC1A and PGC1B predicts cancer incidence in a veteran cohortJacob K Kresovich, Brian T Joyce, Tao Gao, et al.
AIDS (London, England)|September 16, 2015
A prospective, randomized clinical trial of antiretroviral therapies on carotid wall thicknessJames H Stein, Heather J Ribaudo, Howard N Hodis, et al.
Antimicrobial Agents and Chemotherapy|September 23, 2015
Artemether-Lumefantrine Exposure in HIV-Infected Nigerian Subjects on Nevirapine-Containing Antiretroviral TherapySunil Parikh, Fatai Fehintola, Liusheng Huang, et al.
JMIR Public Health and Surveillance|July 16, 2024
South Asia's COVID-19 History and Surveillance: Updated Epidemiological AssessmentLori A Post, Alan G Soetikno, Scott A Wu, et al.
JMIR Public Health and Surveillance|July 16, 2024
Updated Surveillance Metrics and History of the COVID-19 Pandemic (2020-2023) in Sub-Saharan Africa: Longitudinal Trend AnalysisAlexander L Lundberg, Alan G Soetikno, Scott A Wu, et al.
AIDS (London, England)|March 21, 2003
A phase II clinical study of the long-term safety and antiviral activity of enfuvirtide-based antiretroviral therapyJacob P Lalezari, Joseph J Eron, Margrit Carlson, et al.
Infectious Agents and Cancer|December 5, 2019
HIV status, age at cervical Cancer screening and cervical cytology outcomes in an opportunistic screening setting in Nigeria: a 10-year Cross sectional data analysisJonah Musa, Chad J Achenbach, Charlesnika T Evans, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 13, 2015
Superior Effectiveness of Zidovudine Compared With Tenofovir When Combined With Nevirapine-based Antiretroviral Therapy in a Large Nigerian CohortKimberly K Scarsi, Geoffrey Eisen, Kristin M Darin, et al.
AIDS Research and Treatment|April 14, 2012
Nevirapine-Based Antiretroviral Therapy Impacts Artesunate and Dihydroartemisinin Disposition in HIV-Infected Nigerian AdultsFatai A Fehintola, Kimberly K Scarsi, Qing Ma, et al.
Pageof 18